Company Overview of Asmacure Ltée
Asmacure Ltée, a clinical-stage biopharmaceutical company, focuses on the development of proprietary molecules that target cholinergic receptors for the treatment of inflammation (primarily pulmonary airway diseases). It develops ASM-024 for the treatment of moderate asthma and chronic obstructive pulmonary disease with a dry powder for inhalation formulation. The company was founded in 2002 and is based in Quebec City, Canada. As of August 19, 2015, Asmacure Ltée operates as a subsidiary of Odan Laboratories Ltd.
2600, Boulevard Laurier
Quebec City, QC G1V 4W2
Founded in 2002
Key Executives for Asmacure Ltée
Similar Private Companies By Industry
|Protiva Biotherapeutics Inc.||Americas|
|Geneseeq Technology Inc.||Americas|
|Pharma Laser, Inc.||Americas|
|Amgen Canada Inc.||Americas|
|Interface Biologics, Inc.||Americas|
Recent Private Companies Transactions
August 19, 2015
To contact Asmacure Ltée, please visit www.asmacure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.